 |
|||||
| mesothelioma | |||||
| 新闻 | |||||
|
不可切除性胸膜间皮瘤：nivolumab 联合ipilimumab 在5 年随访中持续体现总生存获益
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Annals of oncology : official journal ...
|
|||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
 以RSS Feed的形式接收此快讯 |
|
发送反馈
|
